Peter Donhauser's most recent trade in Anavex Life Sciences Corporation was a trade of 2,835 Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on June 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Purchase of securities on an exchange or from another person at price $ 3.64 per share. | 14 Jun 2024 | 2,835 | 5,000 (0%) | 0% | 3.6 | 10,319 | Common Stock |
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Purchase of securities on an exchange or from another person at price $ 10.93 per share. | 17 May 2021 | 1,000 | 2,165 (0%) | 0% | 10.9 | 10,930 | Common Stock |
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Purchase of securities on an exchange or from another person at price $ 12.62 per share. | 19 Feb 2021 | 1,000 | 1,000 (0%) | 0% | 12.6 | 12,620 | Common Stock |
Anavex Life Sciences Corpo... | Peter Donhauser | Director | Purchase of securities on an exchange or from another person at price $ 12.97 per share. | 19 Feb 2021 | 165 | 1,165 (0%) | 0% | 13.0 | 2,140 | Common Stock |